James Keegan

James Keegan

Associate

James Keegan is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he practices corporate and securities law. He advises public and private companies through all stages of their growth on a variety of corporate matters, including formation and operation, corporate governance, venture capital financings, mergers and acquisitions, public offerings, public company disclosure, and securities law matters.

Experience

Education

J.D., University of San Diego School of Law, 2022

Admissions

State Bar of California

Credentials

Education

J.D., University of San Diego School of Law, 2022

Admissions

State Bar of California

Corporate

Recent Insights

Client Highlights

On October 22, 2024, AvenCell Therapeutics, a leading clinical-stage cell therapy company focused on advancing both autologous and allogeneic switchable CAR-T cell therapies, announced that it has raised $112 million in Series B financing. The financing was led by global life sciences investor Novo Holdings. New investors F-Prime Capital, Eight Roads Ventures Japan, Piper Heartland Healthcare Capital, and NYBC Ventures also participated in the round alongside founding investor Blackstone Life Sciences. Wilson Sonsini Goodrich & Rosati advised Novo Holdings and F-Prime Capital on the transaction.

Learn More

Client Highlights

On January 24, 2023, life sciences technology company Pacific Biosciences of California Inc announced that it has priced a 17.5 million share secondary stock offering at $10 per share. The transaction will raise $175 million, which was upsized from the original size of $150 million. Wilson Sonsini Goodrich & Rosati advised Pacific Biosciences on the transaction.

Learn More